• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病神经病理变化与认知状态的相关性:文献综述。

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

机构信息

Sanders-Brown Center on Aging, Department of Pathology, University of Kentucky, Lexington 40536-0230, USA.

出版信息

J Neuropathol Exp Neurol. 2012 May;71(5):362-81. doi: 10.1097/NEN.0b013e31825018f7.

DOI:10.1097/NEN.0b013e31825018f7
PMID:22487856
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3560290/
Abstract

Clinicopathologic correlation studies are critically important for the field of Alzheimer disease (AD) research. Studies on human subjects with autopsy confirmation entail numerous potential biases that affect both their general applicability and the validity of the correlations. Many sources of data variability can weaken the apparent correlation between cognitive status and AD neuropathologic changes. Indeed, most persons in advanced old age have significant non-AD brain lesions that may alter cognition independently of AD. Worldwide research efforts have evaluated thousands of human subjects to assess the causes of cognitive impairment in the elderly, and these studies have been interpreted in different ways. We review the literature focusing on the correlation of AD neuropathologic changes (i.e. β-amyloid plaques and neurofibrillary tangles) with cognitive impairment. We discuss the various patterns of brain changes that have been observed in elderly individuals to provide a perspective for understanding AD clinicopathologic correlation and conclude that evidence from many independent research centers strongly supports the existence of a specific disease, as defined by the presence of Aβ plaques and neurofibrillary tangles. Although Aβ plaques may play a key role in AD pathogenesis, the severity of cognitive impairment correlates best with the burden of neocortical neurofibrillary tangles.

摘要

临床病理相关性研究对于阿尔茨海默病(AD)研究领域至关重要。对经过尸检证实的人类受试者进行的研究存在许多潜在的偏倚,这些偏倚会影响研究的普遍适用性和相关性的有效性。许多数据变异性来源可能会削弱认知状态与 AD 神经病理变化之间的明显相关性。事实上,大多数高龄人群都有明显的非 AD 脑损伤,这些损伤可能会独立于 AD 改变认知。全球范围内的研究工作已经评估了数千名人类受试者,以评估老年人认知障碍的原因,这些研究已经以不同的方式进行了解读。我们回顾了文献,重点关注 AD 神经病理变化(即β-淀粉样斑块和神经纤维缠结)与认知障碍的相关性。我们讨论了在老年人中观察到的各种大脑变化模式,以提供理解 AD 临床病理相关性的视角,并得出结论,来自许多独立研究中心的证据强烈支持特定疾病的存在,该疾病的定义是存在 Aβ斑块和神经纤维缠结。虽然 Aβ 斑块可能在 AD 的发病机制中起关键作用,但认知障碍的严重程度与新皮质神经纤维缠结的负担相关性最好。

相似文献

1
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.阿尔茨海默病神经病理变化与认知状态的相关性:文献综述。
J Neuropathol Exp Neurol. 2012 May;71(5):362-81. doi: 10.1097/NEN.0b013e31825018f7.
2
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.一个大型阿尔茨海默病中心尸检队列中的临床病理相关性:在对疾病严重程度进行分期时,神经炎性斑块和神经原纤维缠结“确实重要”。
J Neuropathol Exp Neurol. 2007 Dec;66(12):1136-46. doi: 10.1097/nen.0b013e31815c5efb.
3
Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.阿尔茨海默病中的神经病理学与认知障碍:一种复杂但连贯的关系。
J Neuropathol Exp Neurol. 2009 Jan;68(1):1-14. doi: 10.1097/NEN.0b013e3181919a48.
4
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.认知健康老龄化与阿尔茨海默病的临床病理研究:组织学标志物与痴呆严重程度、年龄、性别及载脂蛋白E基因型的关系。
Arch Neurol. 1998 Mar;55(3):326-35. doi: 10.1001/archneur.55.3.326.
5
Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.老年精神分裂症患者中的阿尔茨海默病及相关神经退行性疾病:100例尸检神经病理学研究
Arch Gen Psychiatry. 1998 Mar;55(3):205-11. doi: 10.1001/archpsyc.55.3.205.
6
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.轻度认知障碍与阿尔茨海默病病理及脑梗死有关。
Neurology. 2005 Mar 8;64(5):834-41. doi: 10.1212/01.WNL.0000152982.47274.9E.
7
Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.无细胞内β淀粉样蛋白沉积的皮质与阿尔茨海默病的关系。
JAMA Neurol. 2019 Jul 1;76(7):818-826. doi: 10.1001/jamaneurol.2019.0834.
8
Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.神经原纤维缠结介导淀粉样蛋白负荷与临床阿尔茨海默病及认知功能水平之间的关联。
Arch Neurol. 2004 Mar;61(3):378-84. doi: 10.1001/archneur.61.3.378.
9
Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.用有轻度至中度阿尔茨海默病和最小β-淀粉样肽斑块的临床诊断来描述载脂蛋白 E ε4 携带者和非携带者。
JAMA Neurol. 2015 Oct;72(10):1124-31. doi: 10.1001/jamaneurol.2015.1721.
10
Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques.老年人大脑中缺乏神经原纤维缠结的弥散性β淀粉样斑块和 APOE 对其的影响。
J Alzheimers Dis. 2018;64(4):1307-1324. doi: 10.3233/JAD-180514.

引用本文的文献

1
Twenty years of therapeutic development in tauopathy mouse models: a scoping review.在tau蛋白病小鼠模型中二十年的治疗进展:一项范围综述。
Alzheimers Dement. 2025 Aug;21(8):e70578. doi: 10.1002/alz.70578.
2
Divergent effects of age on imaging-based ATN biomarkers and cognition in Alzheimer's disease.年龄对阿尔茨海默病中基于影像学的急性肾损伤生物标志物及认知功能的不同影响。
Alzheimers Dement (Amst). 2025 Aug 11;17(3):e70142. doi: 10.1002/dad2.70142. eCollection 2025 Jul-Sep.
3
Bridging the molecular and clinical aspects of resveratrol in Alzheimer's disease: a review.

本文引用的文献

1
Neuropathology and general autopsy findings in nondemented aged subjects.非痴呆老年受试者的神经病理学和常规尸检结果。
Clin Neuropathol. 2012 Mar-Apr;31(2):87-98. doi: 10.5414/np300418.
2
Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old.新皮层和海马体的淀粉样蛋白-β和tau 测量与最年长人群的痴呆有关。
Brain. 2011 Dec;134(Pt 12):3708-15. doi: 10.1093/brain/awr308. Epub 2011 Nov 26.
3
Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.
白藜芦醇在阿尔茨海默病中的分子与临床联系:综述
3 Biotech. 2025 Sep;15(9):284. doi: 10.1007/s13205-025-04451-x. Epub 2025 Aug 6.
4
The first 25 years of the Northwestern University SuperAging Program.西北大学超级老龄化项目的头25年。
Alzheimers Dement. 2025 Aug;21(8):e70312. doi: 10.1002/alz.70312.
5
Cognitive impairment and p-tau217 are high in a vascular patient cohort.在一个血管病患者队列中,认知障碍和磷酸化tau217水平较高。
Alzheimers Dement. 2025 Aug;21(8):e70565. doi: 10.1002/alz.70565.
6
An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease.阿尔茨海默病中淀粉样蛋白、tau蛋白和炎症病理生理学之间关系的综合观点。
Alzheimers Dement. 2025 Aug;21(8):e70404. doi: 10.1002/alz.70404.
7
Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies.混合性神经退行性病变患者的认知和神经心理学轨迹
Alzheimers Dement. 2025 Aug;21(8):e70575. doi: 10.1002/alz.70575.
8
Impact of hippocampal α-synuclein oligomers on cognitive trajectory in patients with dementia with Lewy bodies.海马α-突触核蛋白寡聚体对路易体痴呆患者认知轨迹的影响。
Alzheimers Dement. 2025 Aug;21(8):e70374. doi: 10.1002/alz.70374.
9
Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer's disease.轴突tau蛋白减少可改善阿尔茨海默病小鼠模型中的tau蛋白和淀粉样蛋白病理。
Transl Neurodegener. 2025 Jul 29;14(1):39. doi: 10.1186/s40035-025-00499-0.
10
Results of the first-in-human, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study of BIIB113 in healthy volunteers.BIIB113在健康志愿者中进行的首次人体随机双盲安慰剂对照单剂量及多剂量递增研究结果。
J Prev Alzheimers Dis. 2025 Sep;12(8):100302. doi: 10.1016/j.tjpad.2025.100302. Epub 2025 Jul 21.
纹状体淀粉样斑块密度可预测 Braak 神经纤维缠结分期和临床病理阿尔茨海默病:对淀粉样蛋白成像的影响。
J Alzheimers Dis. 2012;28(4):869-76. doi: 10.3233/JAD-2011-111340.
4
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.美国国家老龄化研究所-阿尔茨海默病协会的阿尔茨海默病神经病理学评估指南:实用方法。
Acta Neuropathol. 2012 Jan;123(1):1-11. doi: 10.1007/s00401-011-0910-3. Epub 2011 Nov 20.
5
Aβ-degrading enzymes: potential for treatment of Alzheimer disease.β-淀粉样肽降解酶:阿尔茨海默病治疗的潜力。
J Neuropathol Exp Neurol. 2011 Nov;70(11):944-59. doi: 10.1097/NEN.0b013e3182345e46.
6
Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.阿尔茨海默病病理过程的阶段:年龄类别为 1 至 100 岁。
J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9. doi: 10.1097/NEN.0b013e318232a379.
7
Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study.在两项关于衰老的研究——修女研究和思维老化研究中,未患痴呆的受试者的阿尔茨海默病病理学。
J Neuropathol Exp Neurol. 2011 Oct;70(10):832-40. doi: 10.1097/NEN.0b013e31822e8ae9.
8
Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response.颗粒空泡变性的阶段:与老年痴呆症和慢性应激反应的关系。
Acta Neuropathol. 2011 Nov;122(5):577-89. doi: 10.1007/s00401-011-0871-6. Epub 2011 Sep 21.
9
Resolving controversies on the path to Alzheimer's therapeutics.解决阿尔茨海默病治疗道路上的争议。
Nat Med. 2011 Sep 7;17(9):1060-5. doi: 10.1038/nm.2460.
10
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.阿尔茨海默病的淀粉样蛋白级联假说:治疗药物开发的评估。
Nat Rev Drug Discov. 2011 Aug 19;10(9):698-712. doi: 10.1038/nrd3505.